

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 9.42952558 |
| 2 | cardiac myofibril assembly (GO:0055003) | 8.31649938 |
| 3 | actin-myosin filament sliding (GO:0033275) | 8.17115203 |
| 4 | muscle filament sliding (GO:0030049) | 8.17115203 |
| 5 | myofibril assembly (GO:0030239) | 7.94652696 |
| 6 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 7.73727088 |
| 7 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 7.39045965 |
| 8 | regulation of skeletal muscle contraction (GO:0014819) | 7.10098215 |
| 9 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 6.93596922 |
| 10 | plasma membrane repair (GO:0001778) | 6.75804981 |
| 11 | actin-mediated cell contraction (GO:0070252) | 6.74346018 |
| 12 | cardiac muscle contraction (GO:0060048) | 6.71600290 |
| 13 | tricarboxylic acid cycle (GO:0006099) | 6.36163709 |
| 14 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 6.23680726 |
| 15 | cardiac muscle cell development (GO:0055013) | 6.15516835 |
| 16 | * regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.14131128 |
| 17 | regulation of actin filament-based movement (GO:1903115) | 6.04551201 |
| 18 | actomyosin structure organization (GO:0031032) | 5.93976531 |
| 19 | striated muscle contraction (GO:0006941) | 5.80217157 |
| 20 | cardiac cell development (GO:0055006) | 5.77801021 |
| 21 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.62595323 |
| 22 | carnitine shuttle (GO:0006853) | 5.45286238 |
| 23 | cardiac muscle tissue morphogenesis (GO:0055008) | 5.44383749 |
| 24 | adult heart development (GO:0007512) | 5.43530364 |
| 25 | * regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 5.40421277 |
| 26 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.37847724 |
| 27 | ventricular cardiac muscle cell action potential (GO:0086005) | 5.36232150 |
| 28 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.20450267 |
| 29 | cardiac muscle hypertrophy (GO:0003300) | 5.16640356 |
| 30 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 5.14859543 |
| 31 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 5.12393082 |
| 32 | heart process (GO:0003015) | 5.11004689 |
| 33 | heart contraction (GO:0060047) | 5.11004689 |
| 34 | actin filament-based movement (GO:0030048) | 5.05898722 |
| 35 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 5.04616989 |
| 36 | regulation of sarcomere organization (GO:0060297) | 5.01812132 |
| 37 | striated muscle hypertrophy (GO:0014897) | 4.95863471 |
| 38 | muscle tissue morphogenesis (GO:0060415) | 4.93152409 |
| 39 | skeletal muscle contraction (GO:0003009) | 4.89606381 |
| 40 | * regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.87124192 |
| 41 | heart trabecula formation (GO:0060347) | 4.79379456 |
| 42 | * regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.71778372 |
| 43 | fatty acid transmembrane transport (GO:1902001) | 4.68258426 |
| 44 | * regulation of striated muscle contraction (GO:0006942) | 4.66271450 |
| 45 | regulation of cofactor metabolic process (GO:0051193) | 4.65267646 |
| 46 | regulation of coenzyme metabolic process (GO:0051196) | 4.65267646 |
| 47 | creatine metabolic process (GO:0006600) | 4.57334460 |
| 48 | regulation of membrane repolarization (GO:0060306) | 4.53002864 |
| 49 | muscle hypertrophy (GO:0014896) | 4.38365010 |
| 50 | regulation of the force of heart contraction (GO:0002026) | 4.37866426 |
| 51 | cell communication involved in cardiac conduction (GO:0086065) | 4.27817935 |
| 52 | * regulation of relaxation of muscle (GO:1901077) | 4.21388077 |
| 53 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.20072016 |
| 54 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 4.19721697 |
| 55 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.17213557 |
| 56 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.13982777 |
| 57 | carnitine transmembrane transport (GO:1902603) | 4.03804774 |
| 58 | response to inactivity (GO:0014854) | 4.03119341 |
| 59 | NADH metabolic process (GO:0006734) | 4.01132580 |
| 60 | skeletal muscle adaptation (GO:0043501) | 4.01067929 |
| 61 | 2-oxoglutarate metabolic process (GO:0006103) | 3.96199074 |
| 62 | respiratory electron transport chain (GO:0022904) | 3.94846689 |
| 63 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.94107001 |
| 64 | * muscle contraction (GO:0006936) | 3.92584805 |
| 65 | regulation of sequestering of triglyceride (GO:0010889) | 3.91318952 |
| 66 | ATP synthesis coupled proton transport (GO:0015986) | 3.89228473 |
| 67 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.89228473 |
| 68 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.86003541 |
| 69 | detection of calcium ion (GO:0005513) | 3.84552369 |
| 70 | regulation of ATPase activity (GO:0043462) | 3.84012619 |
| 71 | regulation of ATP catabolic process (GO:1903289) | 3.84012619 |
| 72 | electron transport chain (GO:0022900) | 3.82476076 |
| 73 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.81947130 |
| 74 | cardiac chamber formation (GO:0003207) | 3.80874353 |
| 75 | striated muscle cell development (GO:0055002) | 3.80543096 |
| 76 | * regulation of cell communication by electrical coupling (GO:0010649) | 3.80345301 |
| 77 | negative regulation of potassium ion transport (GO:0043267) | 3.79858251 |
| 78 | negative regulation of protein localization to cell surface (GO:2000009) | 3.79331483 |
| 79 | oxidative phosphorylation (GO:0006119) | 3.79173057 |
| 80 | cardiac muscle cell action potential (GO:0086001) | 3.78579020 |
| 81 | regulation of sulfur metabolic process (GO:0042762) | 3.78420474 |
| 82 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.71078551 |
| 83 | muscle hypertrophy in response to stress (GO:0003299) | 3.71078551 |
| 84 | cardiac muscle adaptation (GO:0014887) | 3.71078551 |
| 85 | positive regulation of cation channel activity (GO:2001259) | 3.70816222 |
| 86 | cardiac ventricle formation (GO:0003211) | 3.70084935 |
| 87 | striated muscle adaptation (GO:0014888) | 3.69506097 |
| 88 | muscle fiber development (GO:0048747) | 3.68830104 |
| 89 | carnitine transport (GO:0015879) | 3.67368759 |
| 90 | amino-acid betaine transport (GO:0015838) | 3.67368759 |
| 91 | * muscle system process (GO:0003012) | 3.65321568 |
| 92 | oxygen transport (GO:0015671) | 3.64697661 |
| 93 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.63689756 |
| 94 | response to caffeine (GO:0031000) | 3.61108915 |
| 95 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.58617390 |
| 96 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.58617390 |
| 97 | * regulation of muscle contraction (GO:0006937) | 3.57293257 |
| 98 | * regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.55866959 |
| 99 | * regulation of calcium ion transmembrane transport (GO:1903169) | 3.55866959 |
| 100 | * regulation of heart rate (GO:0002027) | 3.55440080 |
| 101 | relaxation of cardiac muscle (GO:0055119) | 3.54567197 |
| 102 | cell communication by electrical coupling (GO:0010644) | 3.52986207 |
| 103 | * regulation of cardiac muscle contraction (GO:0055117) | 3.48965858 |
| 104 | muscle adaptation (GO:0043500) | 3.48605811 |
| 105 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.46090084 |
| 106 | * regulation of muscle system process (GO:0090257) | 3.45144734 |
| 107 | response to muscle activity (GO:0014850) | 3.44601863 |
| 108 | * regulation of heart contraction (GO:0008016) | 3.41702017 |
| 109 | striated muscle atrophy (GO:0014891) | 3.40793633 |
| 110 | glycogen catabolic process (GO:0005980) | 3.38693175 |
| 111 | muscle cell cellular homeostasis (GO:0046716) | 3.37910057 |
| 112 | response to epinephrine (GO:0071871) | 3.36671205 |
| 113 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.36295585 |
| 114 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 3.33939084 |
| 115 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.31299024 |
| 116 | skeletal muscle fiber development (GO:0048741) | 3.31149353 |
| 117 | cardiac conduction (GO:0061337) | 3.30930249 |
| 118 | regulation of cardioblast differentiation (GO:0051890) | 3.27928410 |
| 119 | cellular response to epinephrine stimulus (GO:0071872) | 3.27253636 |
| 120 | aspartate family amino acid catabolic process (GO:0009068) | 3.26760814 |
| 121 | muscle cell development (GO:0055001) | 3.25783200 |
| 122 | skeletal muscle tissue development (GO:0007519) | 3.25576568 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.55583532 |
| 2 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 4.52668807 |
| 3 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 4.36278669 |
| 4 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 4.07982426 |
| 5 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 4.07982426 |
| 6 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.99744279 |
| 7 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.40744605 |
| 8 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.32259085 |
| 9 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.29919921 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.29263884 |
| 11 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.97270767 |
| 12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.82463503 |
| 13 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.56604080 |
| 14 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.32400162 |
| 15 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.27955965 |
| 16 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.23122976 |
| 17 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.18463029 |
| 18 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.07586015 |
| 19 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.02488208 |
| 20 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.95382924 |
| 21 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.92639997 |
| 22 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.90661872 |
| 23 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.90611404 |
| 24 | VDR_22108803_ChIP-Seq_LS180_Human | 1.79427614 |
| 25 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.77259555 |
| 26 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.73543788 |
| 27 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.70952254 |
| 28 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.61650377 |
| 29 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.57719195 |
| 30 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.56032664 |
| 31 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.46693273 |
| 32 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.37048291 |
| 33 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.36842100 |
| 34 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.35692978 |
| 35 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.35040575 |
| 36 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.33145817 |
| 37 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.32617042 |
| 38 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.30924997 |
| 39 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.30861989 |
| 40 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.26752889 |
| 41 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.24872713 |
| 42 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.22436437 |
| 43 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.21215198 |
| 44 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.17542099 |
| 45 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.17502388 |
| 46 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.17239881 |
| 47 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.15447967 |
| 48 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.13349425 |
| 49 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.12759317 |
| 50 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.11914267 |
| 51 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.08723012 |
| 52 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.07719398 |
| 53 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.06501275 |
| 54 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.06300654 |
| 55 | GATA1_19941826_ChIP-Seq_K562_Human | 1.06006018 |
| 56 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.04369414 |
| 57 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.01749587 |
| 58 | P68_20966046_ChIP-Seq_HELA_Human | 1.01214332 |
| 59 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.01198999 |
| 60 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.00888618 |
| 61 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.00887498 |
| 62 | ATF3_27146783_Chip-Seq_COLON_Human | 1.00608870 |
| 63 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.99376426 |
| 64 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.98455111 |
| 65 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.97741938 |
| 66 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.96862429 |
| 67 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.96613536 |
| 68 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.96490046 |
| 69 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.95628422 |
| 70 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.93695337 |
| 71 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.93432474 |
| 72 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.93127174 |
| 73 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.93127174 |
| 74 | GATA1_22025678_ChIP-Seq_K562_Human | 0.92992335 |
| 75 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.92394413 |
| 76 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.92088587 |
| 77 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.91483717 |
| 78 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.91403683 |
| 79 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.90914287 |
| 80 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.90700661 |
| 81 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.90393232 |
| 82 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.90092559 |
| 83 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.89891207 |
| 84 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89843339 |
| 85 | * OCT4_20526341_ChIP-Seq_ESCs_Human | 0.89663972 |
| 86 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.89498469 |
| 87 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.89465416 |
| 88 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.89150898 |
| 89 | * ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.89136661 |
| 90 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.88559925 |
| 91 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.88392102 |
| 92 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.88242206 |
| 93 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.88007482 |
| 94 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.87853140 |
| 95 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.87064779 |
| 96 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.86991443 |
| 97 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.86822815 |
| 98 | GATA2_19941826_ChIP-Seq_K562_Human | 0.85913983 |
| 99 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.85598590 |
| 100 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.85223357 |
| 101 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84992601 |
| 102 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.84578665 |
| 103 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.84176189 |
| 104 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.84097345 |
| 105 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.83558726 |
| 106 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.83519367 |
| 107 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.83419512 |
| 108 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.83346162 |
| 109 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.82368088 |
| 110 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.82127970 |
| 111 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.81981521 |
| 112 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.81799365 |
| 113 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.81509314 |
| 114 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.80338246 |
| 115 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.79934734 |
| 116 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.79918096 |
| 117 | CJUN_26792858_Chip-Seq_BT549_Human | 0.79764771 |
| 118 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.79405627 |
| 119 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.78756456 |
| 120 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.78374380 |
| 121 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.78348533 |
| 122 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.78272283 |
| 123 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.78269171 |
| 124 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.77716550 |
| 125 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.76624565 |
| 126 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.76509372 |
| 127 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.76034243 |
| 128 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.75607632 |
| 129 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.75212597 |
| 130 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.75159584 |
| 131 | SPI1_23127762_ChIP-Seq_K562_Human | 0.74471969 |
| 132 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.74187922 |
| 133 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73938148 |
| 134 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.73390824 |
| 135 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.73297704 |
| 136 | SA1_27219007_Chip-Seq_Bcells_Human | 0.73007571 |
| 137 | TBL1_22424771_ChIP-Seq_293T_Human | 0.72855401 |
| 138 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.72162163 |
| 139 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.70868502 |
| 140 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.70642863 |
| 141 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.70251839 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 6.89248225 |
| 2 | MP0003646_muscle_fatigue | 6.28738796 |
| 3 | MP0000751_myopathy | 5.45602288 |
| 4 | MP0004084_abnormal_cardiac_muscle | 5.29179118 |
| 5 | MP0004215_abnormal_myocardial_fiber | 4.44261250 |
| 6 | MP0000749_muscle_degeneration | 4.40551942 |
| 7 | MP0004036_abnormal_muscle_relaxation | 4.34366678 |
| 8 | MP0005330_cardiomyopathy | 3.71531115 |
| 9 | MP0004087_abnormal_muscle_fiber | 3.24288470 |
| 10 | MP0004145_abnormal_muscle_electrophysio | 3.12888629 |
| 11 | MP0002972_abnormal_cardiac_muscle | 2.96188055 |
| 12 | MP0000750_abnormal_muscle_regeneration | 2.93434983 |
| 13 | MP0002106_abnormal_muscle_physiology | 2.87551228 |
| 14 | MP0005620_abnormal_muscle_contractility | 2.83409150 |
| 15 | MP0004130_abnormal_muscle_cell | 2.71814117 |
| 16 | MP0003137_abnormal_impulse_conducting | 2.66685473 |
| 17 | MP0008775_abnormal_heart_ventricle | 2.62860847 |
| 18 | MP0002269_muscular_atrophy | 2.57686016 |
| 19 | MP0010630_abnormal_cardiac_muscle | 2.46740273 |
| 20 | MP0001544_abnormal_cardiovascular_syste | 2.45345794 |
| 21 | MP0005385_cardiovascular_system_phenoty | 2.45345794 |
| 22 | MP0000747_muscle_weakness | 2.39121141 |
| 23 | MP0005369_muscle_phenotype | 2.34413082 |
| 24 | * MP0000759_abnormal_skeletal_muscle | 2.27172760 |
| 25 | MP0006138_congestive_heart_failure | 2.23591523 |
| 26 | * MP0004484_altered_response_of | 2.03763481 |
| 27 | MP0003828_pulmonary_edema | 2.03416171 |
| 28 | MP0004085_abnormal_heartbeat | 1.90922299 |
| 29 | MP0003221_abnormal_cardiomyocyte_apopto | 1.90592909 |
| 30 | MP0004233_abnormal_muscle_weight | 1.90323618 |
| 31 | MP0006036_abnormal_mitochondrial_physio | 1.80691227 |
| 32 | MP0004510_myositis | 1.73004388 |
| 33 | MP0002332_abnormal_exercise_endurance | 1.59837954 |
| 34 | MP0005666_abnormal_adipose_tissue | 1.53731696 |
| 35 | MP0002127_abnormal_cardiovascular_syste | 1.48693832 |
| 36 | MP0003950_abnormal_plasma_membrane | 1.44908468 |
| 37 | MP0005670_abnormal_white_adipose | 1.31522502 |
| 38 | MP0004185_abnormal_adipocyte_glucose | 1.18240864 |
| 39 | MP0000343_altered_response_to | 1.16666943 |
| 40 | MP0003567_abnormal_fetal_cardiomyocyte | 1.11614702 |
| 41 | MP0002234_abnormal_pharynx_morphology | 1.09922533 |
| 42 | MP0000266_abnormal_heart_morphology | 1.07432748 |
| 43 | MP0002108_abnormal_muscle_morphology | 1.05180693 |
| 44 | MP0005375_adipose_tissue_phenotype | 1.03500223 |
| 45 | MP0001661_extended_life_span | 1.03092627 |
| 46 | MP0006035_abnormal_mitochondrial_morpho | 1.02156470 |
| 47 | MP0010368_abnormal_lymphatic_system | 0.92325121 |
| 48 | MP0003279_aneurysm | 0.91379908 |
| 49 | MP0005266_abnormal_metabolism | 0.90308484 |
| 50 | MP0000733_abnormal_muscle_development | 0.86364533 |
| 51 | MP0000230_abnormal_systemic_arterial | 0.75627110 |
| 52 | MP0003806_abnormal_nucleotide_metabolis | 0.74759615 |
| 53 | MP0003705_abnormal_hypodermis_morpholog | 0.72993731 |
| 54 | MP0002128_abnormal_blood_circulation | 0.72718043 |
| 55 | * MP0005165_increased_susceptibility_to | 0.70086707 |
| 56 | MP0004270_analgesia | 0.69606171 |
| 57 | MP0002971_abnormal_brown_adipose | 0.68438039 |
| 58 | MP0004043_abnormal_pH_regulation | 0.65768849 |
| 59 | MP0003566_abnormal_cell_adhesion | 0.63176272 |
| 60 | MP0005623_abnormal_meninges_morphology | 0.63124480 |
| 61 | MP0002909_abnormal_adrenal_gland | 0.61648986 |
| 62 | MP0004147_increased_porphyrin_level | 0.56272876 |
| 63 | MP0001879_abnormal_lymphatic_vessel | 0.56242059 |
| 64 | MP0000003_abnormal_adipose_tissue | 0.55708451 |
| 65 | MP0000013_abnormal_adipose_tissue | 0.52034204 |
| 66 | MP0000767_abnormal_smooth_muscle | 0.51822238 |
| 67 | MP0002078_abnormal_glucose_homeostasis | 0.50410535 |
| 68 | MP0005187_abnormal_penis_morphology | 0.50329045 |
| 69 | MP0005451_abnormal_body_composition | 0.49266600 |
| 70 | MP0005319_abnormal_enzyme/_coenzyme | 0.48081696 |
| 71 | MP0008961_abnormal_basal_metabolism | 0.45546447 |
| 72 | MP0001299_abnormal_eye_distance/ | 0.45281843 |
| 73 | MP0005275_abnormal_skin_tensile | 0.44913488 |
| 74 | MP0008438_abnormal_cutaneous_collagen | 0.42150400 |
| 75 | MP0002925_abnormal_cardiovascular_devel | 0.39523756 |
| 76 | MP0005535_abnormal_body_temperature | 0.33883988 |
| 77 | MP0002638_abnormal_pupillary_reflex | 0.33665822 |
| 78 | MP0003948_abnormal_gas_homeostasis | 0.31733014 |
| 79 | MP0004272_abnormal_basement_membrane | 0.31691450 |
| 80 | MP0005083_abnormal_biliary_tract | 0.31520840 |
| 81 | MP0005503_abnormal_tendon_morphology | 0.31044373 |
| 82 | MP0002822_catalepsy | 0.30723919 |
| 83 | MP0001614_abnormal_blood_vessel | 0.30586081 |
| 84 | MP0001784_abnormal_fluid_regulation | 0.29807445 |
| 85 | MP0003984_embryonic_growth_retardation | 0.29338259 |
| 86 | MP0003941_abnormal_skin_development | 0.29120411 |
| 87 | MP0002088_abnormal_embryonic_growth/wei | 0.28022417 |
| 88 | MP0005376_homeostasis/metabolism_phenot | 0.28011917 |
| 89 | MP0002295_abnormal_pulmonary_circulatio | 0.26460204 |
| 90 | MP0009115_abnormal_fat_cell | 0.26339991 |
| 91 | MP0009840_abnormal_foam_cell | 0.25921086 |
| 92 | MP0002118_abnormal_lipid_homeostasis | 0.25313380 |
| 93 | MP0003195_calcinosis | 0.25146848 |
| 94 | MP0001984_abnormal_olfaction | 0.24459719 |
| 95 | MP0003045_fibrosis | 0.23254590 |
| 96 | MP0001853_heart_inflammation | 0.23222350 |
| 97 | MP0003656_abnormal_erythrocyte_physiolo | 0.23145910 |
| 98 | MP0005332_abnormal_amino_acid | 0.23135667 |
| 99 | MP0009384_cardiac_valve_regurgitation | 0.22617389 |
| 100 | * MP0005334_abnormal_fat_pad | 0.22562504 |
| 101 | MP0005386_behavior/neurological_phenoty | 0.22335677 |
| 102 | MP0004924_abnormal_behavior | 0.22335677 |
| 103 | MP0009780_abnormal_chondrocyte_physiolo | 0.22106948 |
| 104 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.21899632 |
| 105 | MP0000372_irregular_coat_pigmentation | 0.21704787 |
| 106 | MP0000762_abnormal_tongue_morphology | 0.21587350 |
| 107 | MP0008004_abnormal_stomach_pH | 0.20954756 |
| 108 | MP0001727_abnormal_embryo_implantation | 0.20574754 |
| 109 | MP0005595_abnormal_vascular_smooth | 0.20544350 |
| 110 | MP0005452_abnormal_adipose_tissue | 0.20276375 |
| 111 | MP0002877_abnormal_melanocyte_morpholog | 0.20225292 |
| 112 | MP0008569_lethality_at_weaning | 0.19857567 |
| 113 | MP0001958_emphysema | 0.19758375 |
| 114 | MP0005167_abnormal_blood-brain_barrier | 0.19108467 |
| 115 | MP0000249_abnormal_blood_vessel | 0.17993506 |
| 116 | MP0002896_abnormal_bone_mineralization | 0.17216676 |
| 117 | MP0005409_darkened_coat_color | 0.16200271 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 7.50879764 |
| 2 | Calf muscle hypertrophy (HP:0008981) | 6.95403422 |
| 3 | Exercise-induced myalgia (HP:0003738) | 6.79357518 |
| 4 | Exercise-induced muscle cramps (HP:0003710) | 6.65993636 |
| 5 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.65859023 |
| 6 | Ventricular tachycardia (HP:0004756) | 6.54026315 |
| 7 | Muscle fiber splitting (HP:0003555) | 6.03570846 |
| 8 | Atrial fibrillation (HP:0005110) | 5.44079405 |
| 9 | Abnormality of the calf musculature (HP:0001430) | 5.43637035 |
| 10 | Hyporeflexia of lower limbs (HP:0002600) | 5.30192969 |
| 11 | Myoglobinuria (HP:0002913) | 5.23780802 |
| 12 | Primary atrial arrhythmia (HP:0001692) | 5.08688422 |
| 13 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.98147928 |
| 14 | Subaortic stenosis (HP:0001682) | 4.98147928 |
| 15 | Lipoatrophy (HP:0100578) | 4.95565664 |
| 16 | Supraventricular tachycardia (HP:0004755) | 4.91948178 |
| 17 | Supraventricular arrhythmia (HP:0005115) | 4.81480683 |
| 18 | EMG: myopathic abnormalities (HP:0003458) | 4.60710755 |
| 19 | Right ventricular cardiomyopathy (HP:0011663) | 4.57218168 |
| 20 | Increased connective tissue (HP:0009025) | 4.40155051 |
| 21 | Difficulty running (HP:0009046) | 4.33776358 |
| 22 | Bundle branch block (HP:0011710) | 4.31498879 |
| 23 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.22628899 |
| 24 | Dilated cardiomyopathy (HP:0001644) | 4.18870549 |
| 25 | Syncope (HP:0001279) | 4.14697062 |
| 26 | Rhabdomyolysis (HP:0003201) | 4.08443228 |
| 27 | Asymmetric septal hypertrophy (HP:0001670) | 4.04120729 |
| 28 | Palpitations (HP:0001962) | 4.03082868 |
| 29 | Muscle fiber inclusion bodies (HP:0100299) | 3.95824783 |
| 30 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.89008496 |
| 31 | Myotonia (HP:0002486) | 3.84796149 |
| 32 | Prolonged QT interval (HP:0001657) | 3.80149926 |
| 33 | Heart block (HP:0012722) | 3.58261262 |
| 34 | Ventricular arrhythmia (HP:0004308) | 3.57134601 |
| 35 | Type 1 muscle fiber predominance (HP:0003803) | 3.52026940 |
| 36 | Abnormal atrioventricular conduction (HP:0005150) | 3.38610838 |
| 37 | Atrioventricular block (HP:0001678) | 3.36878364 |
| 38 | Difficulty climbing stairs (HP:0003551) | 3.32759232 |
| 39 | Nemaline bodies (HP:0003798) | 3.19778845 |
| 40 | Ulnar deviation of the wrist (HP:0003049) | 3.18098332 |
| 41 | Ventricular fibrillation (HP:0001663) | 3.15339966 |
| 42 | Muscle stiffness (HP:0003552) | 3.07668296 |
| 43 | Increased variability in muscle fiber diameter (HP:0003557) | 2.91387748 |
| 44 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.84306976 |
| 45 | Distal lower limb muscle weakness (HP:0009053) | 2.83679605 |
| 46 | Areflexia of lower limbs (HP:0002522) | 2.80252704 |
| 47 | Hepatic necrosis (HP:0002605) | 2.77519148 |
| 48 | Left ventricular hypertrophy (HP:0001712) | 2.75025847 |
| 49 | Abnormal EKG (HP:0003115) | 2.74242503 |
| 50 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.73945865 |
| 51 | Neck muscle weakness (HP:0000467) | 2.73314611 |
| 52 | Acute necrotizing encephalopathy (HP:0006965) | 2.70679883 |
| 53 | Calcaneovalgus deformity (HP:0001848) | 2.67417355 |
| 54 | Limb-girdle muscle atrophy (HP:0003797) | 2.58865319 |
| 55 | Ketoacidosis (HP:0001993) | 2.56508096 |
| 56 | Palmoplantar keratoderma (HP:0000982) | 2.46567242 |
| 57 | Hepatocellular necrosis (HP:0001404) | 2.44639382 |
| 58 | Testicular atrophy (HP:0000029) | 2.44533627 |
| 59 | Rimmed vacuoles (HP:0003805) | 2.40720102 |
| 60 | Bulbar palsy (HP:0001283) | 2.39200229 |
| 61 | Absent phalangeal crease (HP:0006109) | 2.37210642 |
| 62 | Distal arthrogryposis (HP:0005684) | 2.36019108 |
| 63 | Deformed tarsal bones (HP:0008119) | 2.34818871 |
| 64 | Acute encephalopathy (HP:0006846) | 2.33898022 |
| 65 | Increased muscle lipid content (HP:0009058) | 2.32438640 |
| 66 | Malignant hyperthermia (HP:0002047) | 2.30206764 |
| 67 | Hypoglycemic coma (HP:0001325) | 2.28518100 |
| 68 | Myopathic facies (HP:0002058) | 2.24878751 |
| 69 | Mitochondrial inheritance (HP:0001427) | 2.23883412 |
| 70 | Round ear (HP:0100830) | 2.23757260 |
| 71 | Distal lower limb amyotrophy (HP:0008944) | 2.23450662 |
| 72 | Hypoplastic ischia (HP:0003175) | 2.23287956 |
| 73 | Progressive macrocephaly (HP:0004481) | 2.23271485 |
| 74 | Muscular dystrophy (HP:0003560) | 2.18002017 |
| 75 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.16051421 |
| 76 | Progressive muscle weakness (HP:0003323) | 2.15915249 |
| 77 | Weak cry (HP:0001612) | 2.15027980 |
| 78 | EMG: neuropathic changes (HP:0003445) | 2.14846975 |
| 79 | Cerebral edema (HP:0002181) | 2.14603108 |
| 80 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.12861682 |
| 81 | Exercise intolerance (HP:0003546) | 2.12483400 |
| 82 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.11792104 |
| 83 | Dicarboxylic aciduria (HP:0003215) | 2.11792104 |
| 84 | Increased CSF lactate (HP:0002490) | 2.11035690 |
| 85 | Gowers sign (HP:0003391) | 2.10623619 |
| 86 | Conjunctival hamartoma (HP:0100780) | 2.06881070 |
| 87 | Generalized muscle weakness (HP:0003324) | 2.05261475 |
| 88 | Facial diplegia (HP:0001349) | 2.04843083 |
| 89 | Abnormality of the foot musculature (HP:0001436) | 2.02881682 |
| 90 | Lower limb amyotrophy (HP:0007210) | 2.02220806 |
| 91 | Increased intramyocellular lipid droplets (HP:0012240) | 2.01534269 |
| 92 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.99540866 |
| 93 | Ragged-red muscle fibers (HP:0003200) | 1.97487302 |
| 94 | Foot dorsiflexor weakness (HP:0009027) | 1.97094814 |
| 95 | Abnormality of the ischium (HP:0003174) | 1.94107370 |
| 96 | Lactic acidosis (HP:0003128) | 1.92523130 |
| 97 | Ketosis (HP:0001946) | 1.92398889 |
| 98 | Hip contracture (HP:0003273) | 1.91907306 |
| 99 | Large for gestational age (HP:0001520) | 1.90893295 |
| 100 | Abnormal finger flexion creases (HP:0006143) | 1.90651293 |
| 101 | Fatigable weakness (HP:0003473) | 1.90202286 |
| 102 | Abnormality of the neuromuscular junction (HP:0003398) | 1.90202286 |
| 103 | Scapular winging (HP:0003691) | 1.89877713 |
| 104 | Respiratory failure (HP:0002878) | 1.88834280 |
| 105 | Congestive heart failure (HP:0001635) | 1.87953370 |
| 106 | Proximal amyotrophy (HP:0007126) | 1.87118318 |
| 107 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.86297599 |
| 108 | Abnormality of alanine metabolism (HP:0010916) | 1.85925454 |
| 109 | Hyperalaninemia (HP:0003348) | 1.85925454 |
| 110 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.85925454 |
| 111 | Steppage gait (HP:0003376) | 1.85829595 |
| 112 | Hypoplastic heart (HP:0001961) | 1.84738204 |
| 113 | Sudden cardiac death (HP:0001645) | 1.84407488 |
| 114 | Dysmetric saccades (HP:0000641) | 1.82491523 |
| 115 | Fetal akinesia sequence (HP:0001989) | 1.80478494 |
| 116 | Limb-girdle muscle weakness (HP:0003325) | 1.80032846 |
| 117 | Frequent falls (HP:0002359) | 1.79843741 |
| 118 | Pheochromocytoma (HP:0002666) | 1.79497111 |
| 119 | Increased serum pyruvate (HP:0003542) | 1.79146231 |
| 120 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.78245155 |
| 121 | Waddling gait (HP:0002515) | 1.77291181 |
| 122 | Abnormality of the tricuspid valve (HP:0001702) | 1.76114606 |
| 123 | Abnormality of glycolysis (HP:0004366) | 1.69321272 |
| 124 | Hypoplastic left heart (HP:0004383) | 1.63851956 |
| 125 | Spinal rigidity (HP:0003306) | 1.63251266 |
| 126 | Aplasia of the musculature (HP:0100854) | 1.62891999 |
| 127 | Hyperkalemia (HP:0002153) | 1.50228828 |
| 128 | Abnormality of the calcaneus (HP:0008364) | 1.44973356 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 6.66831841 |
| 2 | OBSCN | 4.99263985 |
| 3 | PHKG2 | 4.65749632 |
| 4 | PHKG1 | 4.65749632 |
| 5 | LMTK2 | 3.46287795 |
| 6 | PDK3 | 3.30080601 |
| 7 | PDK4 | 3.30080601 |
| 8 | MYLK | 3.22602635 |
| 9 | DMPK | 2.95704253 |
| 10 | TRIB3 | 2.54249918 |
| 11 | PKN2 | 2.53285240 |
| 12 | BCKDK | 2.49736715 |
| 13 | PIK3CA | 2.38327468 |
| 14 | MUSK | 2.33208383 |
| 15 | NEK1 | 2.29611619 |
| 16 | PINK1 | 2.16990452 |
| 17 | PDK2 | 2.01981734 |
| 18 | TIE1 | 1.77390668 |
| 19 | STK24 | 1.60781692 |
| 20 | GRK7 | 1.39696835 |
| 21 | MARK1 | 1.36431291 |
| 22 | PAK3 | 1.27474178 |
| 23 | MAP3K7 | 1.26681129 |
| 24 | MAP2K3 | 1.23749347 |
| 25 | PRKD1 | 1.20274001 |
| 26 | LIMK1 | 1.19581025 |
| 27 | CAMK2D | 1.16933649 |
| 28 | MAPK12 | 1.15580993 |
| 29 | NME1 | 1.10538285 |
| 30 | ILK | 1.03173043 |
| 31 | MAPKAPK3 | 0.91908545 |
| 32 | PRKAA1 | 0.89983057 |
| 33 | ROCK1 | 0.89903177 |
| 34 | EEF2K | 0.88936840 |
| 35 | PRKAA2 | 0.87570620 |
| 36 | STK4 | 0.86271087 |
| 37 | MAP3K6 | 0.85842404 |
| 38 | ZAK | 0.85523627 |
| 39 | MAP3K5 | 0.85497978 |
| 40 | RIPK1 | 0.84630118 |
| 41 | TRPM7 | 0.83696703 |
| 42 | PKN1 | 0.83415811 |
| 43 | PIK3CG | 0.79970304 |
| 44 | CDC42BPA | 0.78334514 |
| 45 | WNK4 | 0.78143697 |
| 46 | INSRR | 0.73775892 |
| 47 | EPHA3 | 0.69671790 |
| 48 | STK38L | 0.68906528 |
| 49 | MAP3K3 | 0.68124552 |
| 50 | FLT3 | 0.67307380 |
| 51 | PDGFRA | 0.66943735 |
| 52 | CAMK4 | 0.63890762 |
| 53 | EPHB1 | 0.62807016 |
| 54 | DAPK3 | 0.61340737 |
| 55 | MAPK4 | 0.59934991 |
| 56 | ROCK2 | 0.57965620 |
| 57 | MAP2K1 | 0.57476379 |
| 58 | RPS6KL1 | 0.53521874 |
| 59 | RPS6KC1 | 0.53521874 |
| 60 | CAMK2B | 0.53304935 |
| 61 | STK38 | 0.52754872 |
| 62 | WNK1 | 0.51537567 |
| 63 | CAMK2A | 0.51172676 |
| 64 | CCNB1 | 0.51124393 |
| 65 | TGFBR2 | 0.50608264 |
| 66 | PRKACB | 0.49851440 |
| 67 | KDR | 0.46213315 |
| 68 | NEK9 | 0.46041984 |
| 69 | RPS6KA6 | 0.45497168 |
| 70 | MOS | 0.45267652 |
| 71 | KSR2 | 0.44450929 |
| 72 | ICK | 0.42327959 |
| 73 | CAMK1 | 0.39514809 |
| 74 | AKT2 | 0.39273798 |
| 75 | CAMK2G | 0.39133316 |
| 76 | SIK1 | 0.38496195 |
| 77 | PRKACA | 0.38471018 |
| 78 | DYRK1B | 0.37946962 |
| 79 | PTK2B | 0.37229223 |
| 80 | PDPK1 | 0.36189900 |
| 81 | MAP2K4 | 0.35765891 |
| 82 | PRKACG | 0.35727141 |
| 83 | PRKCE | 0.34910839 |
| 84 | MAP2K6 | 0.31834836 |
| 85 | ERBB3 | 0.31322763 |
| 86 | PTK6 | 0.30805860 |
| 87 | FGFR3 | 0.28340164 |
| 88 | RPS6KA1 | 0.27611424 |
| 89 | PDK1 | 0.27375455 |
| 90 | PRKCH | 0.27322079 |
| 91 | TAOK1 | 0.25215380 |
| 92 | MAPK10 | 0.23663772 |
| 93 | SGK2 | 0.22881202 |
| 94 | STK39 | 0.22476617 |
| 95 | MAPK11 | 0.22456278 |
| 96 | PRKG1 | 0.21434648 |
| 97 | PRKD3 | 0.21016819 |
| 98 | SGK1 | 0.20830591 |
| 99 | MTOR | 0.19821544 |
| 100 | NME2 | 0.19327329 |
| 101 | SGK3 | 0.19040143 |
| 102 | JAK1 | 0.18997903 |
| 103 | RPS6KA3 | 0.18242577 |
| 104 | EPHB2 | 0.17669109 |
| 105 | LATS1 | 0.17144423 |
| 106 | FER | 0.16534060 |
| 107 | LATS2 | 0.16165290 |
| 108 | NTRK2 | 0.15960809 |
| 109 | MAPK7 | 0.15737729 |
| 110 | MARK2 | 0.15588816 |
| 111 | NLK | 0.15466514 |
| 112 | MAP3K11 | 0.15083239 |
| 113 | MAP3K1 | 0.14737472 |
| 114 | RPS6KA2 | 0.13516910 |
| 115 | RET | 0.13463059 |
| 116 | PRKG2 | 0.12923097 |
| 117 | ZAP70 | 0.12482178 |
| 118 | RPS6KB2 | 0.12346538 |
| 119 | FGFR4 | 0.11428603 |
| 120 | LRRK2 | 0.09862996 |
| 121 | MARK3 | 0.09105533 |
| 122 | ITK | 0.08936894 |
| 123 | PAK6 | 0.08337709 |
| 124 | UHMK1 | 0.07579074 |
| 125 | MAPK9 | 0.07342713 |
| 126 | SGK494 | 0.07312788 |
| 127 | SGK223 | 0.07312788 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.76057889 |
| 2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.34361383 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.24823164 |
| 4 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.83416472 |
| 5 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.83272678 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.35289350 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.25996132 |
| 8 | Parkinsons disease_Homo sapiens_hsa05012 | 3.11703115 |
| 9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.03067596 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.76975817 |
| 11 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.66065507 |
| 12 | Carbon metabolism_Homo sapiens_hsa01200 | 2.45972756 |
| 13 | Alzheimers disease_Homo sapiens_hsa05010 | 2.35832414 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.24415306 |
| 15 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.18224938 |
| 16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.08481626 |
| 17 | Huntingtons disease_Homo sapiens_hsa05016 | 1.89376869 |
| 18 | Viral myocarditis_Homo sapiens_hsa05416 | 1.83086444 |
| 19 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.76008348 |
| 20 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.75022458 |
| 21 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.41774657 |
| 22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.32856784 |
| 23 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.30072431 |
| 24 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.24714078 |
| 25 | Insulin resistance_Homo sapiens_hsa04931 | 1.18215375 |
| 26 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.17036552 |
| 27 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.13845909 |
| 28 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.13015115 |
| 29 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.09057833 |
| 30 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.08561204 |
| 31 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.06113341 |
| 32 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.03882715 |
| 33 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.98594549 |
| 34 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.85696693 |
| 35 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.79260575 |
| 36 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.79097307 |
| 37 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.78968828 |
| 38 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.77888279 |
| 39 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.77585801 |
| 40 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.74784165 |
| 41 | Lysine degradation_Homo sapiens_hsa00310 | 0.74437671 |
| 42 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.73959452 |
| 43 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.73282960 |
| 44 | Focal adhesion_Homo sapiens_hsa04510 | 0.71947399 |
| 45 | Galactose metabolism_Homo sapiens_hsa00052 | 0.68947452 |
| 46 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.66269798 |
| 47 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.64295319 |
| 48 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.63275966 |
| 49 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.60712948 |
| 50 | Tight junction_Homo sapiens_hsa04530 | 0.59069667 |
| 51 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.56465442 |
| 52 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.55134825 |
| 53 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.54949423 |
| 54 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.49787965 |
| 55 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.49647336 |
| 56 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.47702854 |
| 57 | Peroxisome_Homo sapiens_hsa04146 | 0.47258497 |
| 58 | Circadian rhythm_Homo sapiens_hsa04710 | 0.45852342 |
| 59 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.44602336 |
| 60 | Renin secretion_Homo sapiens_hsa04924 | 0.44182363 |
| 61 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.43856407 |
| 62 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.43189435 |
| 63 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.40267455 |
| 64 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.39121984 |
| 65 | Long-term potentiation_Homo sapiens_hsa04720 | 0.38440819 |
| 66 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.38232268 |
| 67 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.37554827 |
| 68 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.35598298 |
| 69 | Insulin secretion_Homo sapiens_hsa04911 | 0.35305023 |
| 70 | Adherens junction_Homo sapiens_hsa04520 | 0.33036974 |
| 71 | Olfactory transduction_Homo sapiens_hsa04740 | 0.31342147 |
| 72 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.30687645 |
| 73 | Amoebiasis_Homo sapiens_hsa05146 | 0.30107649 |
| 74 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.28585729 |
| 75 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.27551289 |
| 76 | Sulfur relay system_Homo sapiens_hsa04122 | 0.27488742 |
| 77 | GABAergic synapse_Homo sapiens_hsa04727 | 0.26960336 |
| 78 | Metabolic pathways_Homo sapiens_hsa01100 | 0.23006649 |
| 79 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.22713590 |
| 80 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.22280266 |
| 81 | Prion diseases_Homo sapiens_hsa05020 | 0.21607638 |
| 82 | Melanogenesis_Homo sapiens_hsa04916 | 0.21517728 |
| 83 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.20412306 |
| 84 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.19269429 |
| 85 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.19190182 |
| 86 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.19082082 |
| 87 | Circadian entrainment_Homo sapiens_hsa04713 | 0.18520408 |
| 88 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.18327317 |
| 89 | Morphine addiction_Homo sapiens_hsa05032 | 0.18055404 |
| 90 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.17924444 |
| 91 | Platelet activation_Homo sapiens_hsa04611 | 0.17811622 |
| 92 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.17500708 |
| 93 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.17188070 |
| 94 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.16871953 |
| 95 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.15980677 |
| 96 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.15164783 |
| 97 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.14950240 |
| 98 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.13507851 |
| 99 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.13147613 |
| 100 | Taste transduction_Homo sapiens_hsa04742 | 0.13093570 |
| 101 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.12244023 |
| 102 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.11095197 |
| 103 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.09601541 |
| 104 | Gap junction_Homo sapiens_hsa04540 | 0.08443816 |
| 105 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.08195154 |
| 106 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.07536041 |
| 107 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.05569671 |
| 108 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.05508938 |
| 109 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.03645041 |
| 110 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.03536864 |
| 111 | Bile secretion_Homo sapiens_hsa04976 | 0.03395559 |
| 112 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.03370937 |
| 113 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.02960326 |
| 114 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.02206953 |
| 115 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.00379736 |
| 116 | Salivary secretion_Homo sapiens_hsa04970 | -0.0440226 |
| 117 | ABC transporters_Homo sapiens_hsa02010 | -0.0357748 |

